- Filed
- Apr 22, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 17, 2025 | 143.93M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $14.17B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $14.69B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.69B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.35B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $3.06B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $13.97B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $14.13B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $33.48B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $34.07B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $13.27B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $14.27B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $48.47B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $49.36B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $15.29B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $14.22B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 149.3M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.19B |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $283M |
| Capex | Q1 2025 · Mar 31, 2024 | $270M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$706M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $6.32 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $6.34 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.06B |
| Net Income | Q1 2025 · Mar 31, 2024 | $944M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.07B |
| Revenue | Q1 2025 · Mar 31, 2024 | $10.13B |